Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Melanoma Res. 2016 Dec;26(6):604–608. doi: 10.1097/CMR.0000000000000296

Table 2.

Patient and disease characteristics

Characteristic Number of patients (%)
Sex
 Male 13 (62)
 Female 8 (38)
Age (years)
 Median (range) 65 (25–80)
ECOG performance status
 0 12 (57)
 1 9 (43)
Disease stage
 III unresectable 1
 IVa 2
 IVb 2
 IVc 16
LDH
 Elevated 8
 Normal 13
Number of prior systemic therapies for metastatic disease
 0 7
 1 11
 2 2
 3 1
Brain metastases prior to study entry
 Yes 10
 No 11